Related Experiment Video
Updated: Aug 17, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Response to hepatitis B vaccine in a cohort of Gambian children
P Carotenuto1, I Quinti, O Pontesilli
1Department of Clinical Medicine, University of Rome La Sapienza, Italy.
Insights
A study on Gambian children found that 4.4% had a poor immune response to the hepatitis B vaccine. Further analysis revealed no correlation with immune complexes, immunoglobulins, or Ig allotypes.
Area of Science:
- Immunology
- Vaccinology
- Pediatric Infectious Diseases
Background:
- Hepatitis B virus (HBV) infection is a significant global health concern.
- Effective vaccination is crucial for preventing HBV transmission, particularly in endemic regions.
- Understanding factors influencing vaccine response in diverse populations is essential for optimizing immunization strategies.
Purpose of the Study:
- To investigate serologic indices associated with poor immune response to plasma-derived hepatitis B vaccine in Gambian children.
- To identify potential factors contributing to subnormal humoral immunity against hepatitis B surface antigen.
Main Methods:
- Analysis of sera from 1000 Gambian children immunized with four doses of hepatitis B vaccine.
- Comparison of serologic markers between children with no/low response and age-, sex-, and village-matched controls with normal response.
- Assessment of circulating immune complexes, rheumatoid factors, serum immunoglobulins (Ig), IgG subclasses, and Ig allotypes.
Main Results:
- 4.4% of children exhibited no or low antibody response to hepatitis B surface antigen.
- No significant differences were observed in circulating immune complexes, rheumatoid factors, serum Ig, IgG subclasses, or Ig allotypes between responders and non-responders.
- Humoral response to hepatitis B vaccine did not correlate with response to tetanus toxoid.
Conclusions:
- Polyclonal B cell activation does not appear to be correlated with subnormal humoral response to hepatitis B vaccine in this cohort.
- Factors other than those investigated likely influence the variable immune response to hepatitis B vaccination in Gambian children.
- Further research is needed to elucidate the mechanisms behind vaccine hypo-responsiveness in specific populations.
Abstract:
In a cohort of 1000 Gambian children immunized with four doses of 10 micrograms of plasma-derived hepatitis B virus vaccine, 44 subjects (4.4%) showed no response (< 10 mIU/ml; 6 subjects) or low specific antibody response (10 to 99 mIU/ml; 38 subjects) to hepatitis B surface antigen. Serologic indices, potentially correlated with low immunologic response, were investigated in sera obtained from these children and in sex-, age- and village-matched controls who showed a normal response. The presence of circulating immune complexes in similar proportion of responding and poorly responding children together with a low prevalence of rheumatoid factors suggested that polyclonal B cell activation was not correlated with the subnormal humoral response. Concentrations of serum immunoglobulin (Ig) and IgG subclasses did not differ in the two groups. Some of the African prevalent Ig allotypes were determined, but no significant differences in the two groups were found. The humoral response to hepatitis B surface antigen did not correlate with the response to tetanus toxoid.
More Related Videos
Related Concept Videos
Cross-reactivity
Vaccinations
Yellow Fever
Hepatitis
Viral Hepatitis I: Introduction

